Wuhan YZY Biopharma Co Ltd

Wuhan YZY Biopharma Co Ltdverified

2496.HK

Price:

$7.09

Market Cap:

$1.25B

Wuhan YZY Biopharma Co., Ltd., a biotechnology company, develops bispecific antibody-based therapies for the treatment of cancer, cancer-related complications, and age-related eye diseases. It develops various product candidates for the treatment of malignant ascites, malignant pleural effusion, solid tumors, pancreatic cancer, hepatocellular carcinoma and other advanced solid tumors, small cell lung cancer, relapsed/refractory multiple myeloma, and HER2-positive solid tumors; and covid 19 indication, as well as wAMD, DME, and other ocular neovascularization-related diseases. The company was founded in 2010 and is based in Wuhan, China.

Industry

Biotechnology

IPO Date

2023-09-26

Stock Exchange

HKSE

Ticker

2496.HK

The PE Ratio as of December 2025 (TTM) for Wuhan YZY Biopharma Co Ltd (2496.HK) is -16.11

According to Wuhan YZY Biopharma Co Ltd’s latest financial reports and current stock price. The company's current PE Ratio is -16.11. This represents a change of -26.41% compared to the average of -21.89 of the last 4 quarters.

Wuhan YZY Biopharma Co Ltd (2496.HK) Historical PE Ratio (quarterly & annually)

How has 2496.HK PE Ratio performed in the past?

The mean historical PE Ratio of Wuhan YZY Biopharma Co Ltd over the last ten years is -13.79. The current -16.11 PE Ratio has changed 11.58% with respect to the historical average. Over the past ten years (40 quarters), 2496.HK's PE Ratio was at its highest in in the March 2022 quarter at 0. The PE Ratio was at its lowest in in the December 2024 quarter at -39.25.

Quarterly (TTM)
Annual

Average

-13.79

Median

-15.07

Minimum

-17.23

Maximum

-7.80

Wuhan YZY Biopharma Co Ltd (2496.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Wuhan YZY Biopharma Co Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 98.05%

Maximum Annual PE Ratio = -7.80

Minimum Annual Increase = -46.91%

Minimum Annual PE Ratio = -17.23

Quarterly (TTM)
Annual
YearPE RatioChange
2024-15.4598.05%
2023-7.80-46.91%
2022-14.69-14.74%

Wuhan YZY Biopharma Co Ltd (2496.HK) Average PE Ratio

How has 2496.HK PE Ratio performed in the past?

The current PE Ratio of Wuhan YZY Biopharma Co Ltd (2496.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-12.64

5-year avg

-13.79

10-year avg

-13.79

Wuhan YZY Biopharma Co Ltd (2496.HK) PE Ratio vs. Peers

How is 2496.HK’s PE Ratio compared to its peers?

Wuhan YZY Biopharma Co Ltd’s PE Ratio is less than Sunho Biologics, Inc. (-11.68), less than Brii Biosciences Limited (-2.82), less than Transcenta Holding Limited (-3.83), less than 3D Medicines Inc. (-6.60), less than Broncus Holding Corporation (-10.05), less than Sirnaomics Ltd. (-5.82), less than Kindstar Globalgene Technology, Inc. (-10.31), less than Immunotech Biopharm Ltd (-6.25), less than BioDlink International Company Limited (158.71), less than Beijing Airdoc Technology Co., Ltd. (-6.09),

Build a custom stock screener for Wuhan YZY Biopharma Co Ltd (2496.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Wuhan YZY Biopharma Co Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Wuhan YZY Biopharma Co Ltd (2496.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Wuhan YZY Biopharma Co Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Wuhan YZY Biopharma Co Ltd's PE Ratio?

How is the PE Ratio calculated for Wuhan YZY Biopharma Co Ltd (2496.HK)?

What is the highest PE Ratio for Wuhan YZY Biopharma Co Ltd (2496.HK)?

What is the 3-year average PE Ratio for Wuhan YZY Biopharma Co Ltd (2496.HK)?

What is the 5-year average PE Ratio for Wuhan YZY Biopharma Co Ltd (2496.HK)?

How does the current PE Ratio for Wuhan YZY Biopharma Co Ltd (2496.HK) compare to its historical average?